PEAR1 polymorphisms as a prognostic factor in hemostasis and cardiovascular diseases
Platelet Endothelial Aggregation Receptor (PEAR1), as a platelet receptor, plays a vital role in hemostasis. This receptor, by its extracellular part, causes platelet adhesion and consequently initiates platelet aggregation. Dysfunction of PEAR1 can disrupt platelet aggregation in patients with card...
Saved in:
| Published in | Journal of thrombosis and thrombolysis Vol. 51; no. 1; pp. 89 - 95 |
|---|---|
| Main Authors | , , , |
| Format | Journal Article |
| Language | English |
| Published |
New York
Springer US
01.01.2021
Springer Nature B.V |
| Subjects | |
| Online Access | Get full text |
| ISSN | 0929-5305 1573-742X 1573-742X |
| DOI | 10.1007/s11239-020-02149-w |
Cover
Loading…
| Abstract | Platelet Endothelial Aggregation Receptor (PEAR1), as a platelet receptor, plays a vital role in hemostasis. This receptor, by its extracellular part, causes platelet adhesion and consequently initiates platelet aggregation. Dysfunction of PEAR1 can disrupt platelet aggregation in patients with cardiovascular diseases (CVDs). The content used in this paper has been taken from English language articles (2005–2020) retrieved from Pubmed database and Google scholar search engine using “Cardiovascular Disease”, “PEAR1”, “Polymorphism”, and “Platelet Aggregation” keywords. Some PEAR1 polymorphisms can disrupt homeostasis and interfere with the function mechanism of cardiac drugs. Since polymorphisms in this gene affect platelet function and the platelet aggregation process, PEAR1 could be further studied in the future as an essential factor in controlling the treatment process of patients with cardiovascular diseases. PEAR1 polymorphisms through disruption of the platelet aggregation process can be a risk factor in patients with CVDs. Therefore, controlling patients through genetic testing and the evaluation of PEAR1 polymorphisms can help improve the treatment process of patients. According to the studies on the PEAR1 gene and the effect of different polymorphisms on some crucial issues in CVDs patients (changes in platelet activity), it is clear that if there is a significant relationship between polymorphisms and CVDs, they can be used as prognostic and diagnostic markers. This study aims to evaluate the prognosis and drug treatment of the PEAR1 gene in CVDs patients. |
|---|---|
| AbstractList | Platelet Endothelial Aggregation Receptor (PEAR1), as a platelet receptor, plays a vital role in hemostasis. This receptor, by its extracellular part, causes platelet adhesion and consequently initiates platelet aggregation. Dysfunction of PEAR1 can disrupt platelet aggregation in patients with cardiovascular diseases (CVDs). The content used in this paper has been taken from English language articles (2005–2020) retrieved from Pubmed database and Google scholar search engine using “Cardiovascular Disease”, “PEAR1”, “Polymorphism”, and “Platelet Aggregation” keywords. Some PEAR1 polymorphisms can disrupt homeostasis and interfere with the function mechanism of cardiac drugs. Since polymorphisms in this gene affect platelet function and the platelet aggregation process, PEAR1 could be further studied in the future as an essential factor in controlling the treatment process of patients with cardiovascular diseases. PEAR1 polymorphisms through disruption of the platelet aggregation process can be a risk factor in patients with CVDs. Therefore, controlling patients through genetic testing and the evaluation of PEAR1 polymorphisms can help improve the treatment process of patients. According to the studies on the PEAR1 gene and the effect of different polymorphisms on some crucial issues in CVDs patients (changes in platelet activity), it is clear that if there is a significant relationship between polymorphisms and CVDs, they can be used as prognostic and diagnostic markers. This study aims to evaluate the prognosis and drug treatment of the PEAR1 gene in CVDs patients. Platelet Endothelial Aggregation Receptor (PEAR1), as a platelet receptor, plays a vital role in hemostasis. This receptor, by its extracellular part, causes platelet adhesion and consequently initiates platelet aggregation. Dysfunction of PEAR1 can disrupt platelet aggregation in patients with cardiovascular diseases (CVDs). The content used in this paper has been taken from English language articles (2005-2020) retrieved from Pubmed database and Google scholar search engine using "Cardiovascular Disease", "PEAR1", "Polymorphism", and "Platelet Aggregation" keywords. Some PEAR1 polymorphisms can disrupt homeostasis and interfere with the function mechanism of cardiac drugs. Since polymorphisms in this gene affect platelet function and the platelet aggregation process, PEAR1 could be further studied in the future as an essential factor in controlling the treatment process of patients with cardiovascular diseases. PEAR1 polymorphisms through disruption of the platelet aggregation process can be a risk factor in patients with CVDs. Therefore, controlling patients through genetic testing and the evaluation of PEAR1 polymorphisms can help improve the treatment process of patients. According to the studies on the PEAR1 gene and the effect of different polymorphisms on some crucial issues in CVDs patients (changes in platelet activity), it is clear that if there is a significant relationship between polymorphisms and CVDs, they can be used as prognostic and diagnostic markers. This study aims to evaluate the prognosis and drug treatment of the PEAR1 gene in CVDs patients.Platelet Endothelial Aggregation Receptor (PEAR1), as a platelet receptor, plays a vital role in hemostasis. This receptor, by its extracellular part, causes platelet adhesion and consequently initiates platelet aggregation. Dysfunction of PEAR1 can disrupt platelet aggregation in patients with cardiovascular diseases (CVDs). The content used in this paper has been taken from English language articles (2005-2020) retrieved from Pubmed database and Google scholar search engine using "Cardiovascular Disease", "PEAR1", "Polymorphism", and "Platelet Aggregation" keywords. Some PEAR1 polymorphisms can disrupt homeostasis and interfere with the function mechanism of cardiac drugs. Since polymorphisms in this gene affect platelet function and the platelet aggregation process, PEAR1 could be further studied in the future as an essential factor in controlling the treatment process of patients with cardiovascular diseases. PEAR1 polymorphisms through disruption of the platelet aggregation process can be a risk factor in patients with CVDs. Therefore, controlling patients through genetic testing and the evaluation of PEAR1 polymorphisms can help improve the treatment process of patients. According to the studies on the PEAR1 gene and the effect of different polymorphisms on some crucial issues in CVDs patients (changes in platelet activity), it is clear that if there is a significant relationship between polymorphisms and CVDs, they can be used as prognostic and diagnostic markers. This study aims to evaluate the prognosis and drug treatment of the PEAR1 gene in CVDs patients. |
| Author | Saki, Najmaldin Ansari, Narges Najafi, Sahar Shahrabi, Saied |
| Author_xml | – sequence: 1 givenname: Narges surname: Ansari fullname: Ansari, Narges organization: Department of Internal Medicine, School of Medicine, Isfahan Bone Metabolic Disorders Research Center, Isfahan University of Medical Sciences – sequence: 2 givenname: Sahar surname: Najafi fullname: Najafi, Sahar organization: Thalassemia & Hemoglobinopathy Research Center, Health Research Institute, Ahvaz Jundishapur University of Medical Sciences – sequence: 3 givenname: Saied surname: Shahrabi fullname: Shahrabi, Saied organization: Department of Biochemistry and Hematology, Faculty of Medicine, Semnan University of Medical Sciences – sequence: 4 givenname: Najmaldin surname: Saki fullname: Saki, Najmaldin email: najmaldinsaki@gmail.com organization: Thalassemia & Hemoglobinopathy Research Center, Health Research Institute, Ahvaz Jundishapur University of Medical Sciences |
| BackLink | https://www.ncbi.nlm.nih.gov/pubmed/32445063$$D View this record in MEDLINE/PubMed |
| BookMark | eNp9kU1LHTEUhkOx1OvHH3AhA266mfYkZzI3WYqoLQgtxUJ3IZPJaGQmuebMKP77xl6l4EJICITnObzJu8d2YoqesSMOXzjA-itxLlDXIKBs3uj68QNbcbnGet2IPztsBVroWiLIXbZHdAcAWoP4xHZRNI2EFlfs-uf56S9ebdL4NKW8uQ00UWXLqjY53cREc3DVYN2cchVideuncmUpFCL2lbO5D-nBkltGm6s-kLfk6YB9HOxI_vDl3Ge_L86vz77VVz8uv5-dXtUO13KuNbhOCIm6Q-Gw5YOUuvfCg9JWNoMDiyBw6NUA0Lu2RaU09kLyjneqww732eft3JL1fvE0mymQ8-Noo08LGdGUN0LTNqqgJ2_Qu7TkWNIVSgFHqQALdfxCLd3ke7PJYbL5ybz-VwHUFnA5EWU_GBdmO4cU52zDaDiY52rMthpTqjH_qjGPRRVv1Nfp70q4lajA8cbn_7Hfsf4ClUygGQ |
| CitedBy_id | crossref_primary_10_3389_fphar_2021_797278 crossref_primary_10_5812_jjcdc_123301 crossref_primary_10_1016_j_heliyon_2024_e25760 crossref_primary_10_3390_ijms241813809 crossref_primary_10_1038_s41467_023_36486_0 crossref_primary_10_1002_cbin_11545 crossref_primary_10_1016_j_heliyon_2024_e34552 crossref_primary_10_4103_ccij_ccij_174_20 crossref_primary_10_1038_s41598_024_51458_0 crossref_primary_10_1016_j_molmed_2023_08_002 crossref_primary_10_1097_MD_0000000000038031 crossref_primary_10_2478_acm_2022_0005 |
| Cites_doi | 10.1074/mcp.M114.046946 10.1016/j.bcmd.2005.12.026 10.3390/ijms19041069 10.1371/journal.pone.0111816 10.1042/bj20150192 10.3389/fphar.2018.00490 10.1016/j.jacc.2011.12.062 10.1182/blood-2010-11-320788 10.1182/blood-2009-02-202614 10.1016/j.thromres.2018.01.026 10.1182/blood-2015-11-682153 10.1182/bloodadvances.2018024950 10.1080/09537104.2018.1447659 10.1161/atvbaha.108.168971 10.1161/circulationaha.106.667584 10.1074/jbc.M413411200 10.1182/blood-2016-06-723940 10.1160/th12-09-0645 10.1515/hmbci-2013-0055 10.1038/aps.2016.90 10.1182/blood-2012-10-462887 10.3109/09537104.2015.1111321 10.1016/j.jns.2018.03.013 10.1080/00498254.2016.1271962 10.1097/md.0000000000005687 10.1016/j.thromres.2016.08.026 10.1159/000488101 10.1111/ahg.12285 10.2217/pgs.13.108 10.1016/j.amjcard.2006.04.015 10.1038/nrcardio.2017.108 10.1371/journal.pone.0064179 10.1016/j.thromres.2016.02.031 10.5551/jat.39982 10.1097/crd.0000000000000181 10.1186/s12881-017-0411-x 10.3109/08037051.2014.986928 10.1371/journal.pone.0138795 10.1038/ng.604 10.1080/10428194.2019.1630622 10.1007/s12094-019-02132-9 |
| ContentType | Journal Article |
| Copyright | Springer Science+Business Media, LLC, part of Springer Nature 2020 Springer Science+Business Media, LLC, part of Springer Nature 2020. |
| Copyright_xml | – notice: Springer Science+Business Media, LLC, part of Springer Nature 2020 – notice: Springer Science+Business Media, LLC, part of Springer Nature 2020. |
| DBID | AAYXX CITATION NPM 3V. 7TK 7X7 7XB 88E 8AO 8FI 8FJ 8FK ABUWG AFKRA BENPR CCPQU FYUFA GHDGH K9. M0S M1P PHGZM PHGZT PJZUB PKEHL PPXIY PQEST PQQKQ PQUKI PRINS 7X8 |
| DOI | 10.1007/s11239-020-02149-w |
| DatabaseName | CrossRef PubMed ProQuest Central (Corporate) Neurosciences Abstracts Health & Medical Collection ProQuest Central (purchase pre-March 2016) Medical Database (Alumni Edition) ProQuest Pharma Collection Hospital Premium Collection Hospital Premium Collection (Alumni Edition) ProQuest Central (Alumni) (purchase pre-March 2016) ProQuest Central (Alumni) ProQuest Central UK/Ireland ProQuest ProQuest One Health Research Premium Collection Health Research Premium Collection (Alumni) ProQuest Health & Medical Complete (Alumni) ProQuest Health & Medical Collection Medical Database ProQuest Central Premium ProQuest One Academic (New) ProQuest Health & Medical Research Collection ProQuest One Academic Middle East (New) ProQuest One Health & Nursing ProQuest One Academic Eastern Edition (DO NOT USE) ProQuest One Academic ProQuest One Academic UKI Edition ProQuest Central China MEDLINE - Academic |
| DatabaseTitle | CrossRef PubMed ProQuest One Academic Middle East (New) ProQuest Health & Medical Complete (Alumni) ProQuest Central (Alumni Edition) ProQuest One Community College ProQuest One Health & Nursing ProQuest Pharma Collection ProQuest Central China ProQuest Central ProQuest Health & Medical Research Collection Health Research Premium Collection Health and Medicine Complete (Alumni Edition) Health & Medical Research Collection ProQuest Central (New) ProQuest Medical Library (Alumni) ProQuest One Academic Eastern Edition ProQuest Hospital Collection Health Research Premium Collection (Alumni) Neurosciences Abstracts ProQuest Hospital Collection (Alumni) ProQuest Health & Medical Complete ProQuest Medical Library ProQuest One Academic UKI Edition ProQuest One Academic ProQuest One Academic (New) ProQuest Central (Alumni) MEDLINE - Academic |
| DatabaseTitleList | PubMed MEDLINE - Academic ProQuest One Academic Middle East (New) |
| Database_xml | – sequence: 1 dbid: NPM name: PubMed url: https://proxy.k.utb.cz/login?url=http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=PubMed sourceTypes: Index Database – sequence: 2 dbid: BENPR name: ProQuest Central url: https://www.proquest.com/central sourceTypes: Aggregation Database |
| DeliveryMethod | fulltext_linktorsrc |
| Discipline | Medicine |
| EISSN | 1573-742X |
| EndPage | 95 |
| ExternalDocumentID | 32445063 10_1007_s11239_020_02149_w |
| Genre | Journal Article Review |
| GroupedDBID | --- -53 -5E -5G -BR -EM -Y2 -~C .86 .VR 06C 06D 0R~ 0VY 1N0 1SB 2.D 203 28- 29L 29~ 2J2 2JN 2JY 2KG 2KM 2LR 2P1 2VQ 2~H 30V 3V. 4.4 406 408 409 40D 40E 53G 5GY 5QI 5VS 67Z 6NX 78A 7X7 88E 8AO 8FI 8FJ 8TC 8UJ 95- 95. 95~ 96X AAAVM AABHQ AACDK AAHNG AAIAL AAJBT AAJKR AANXM AANZL AARHV AARTL AASML AATNV AATVU AAUYE AAWCG AAYIU AAYQN AAYTO AAYZH ABAKF ABBBX ABBXA ABDZT ABECU ABFTV ABHLI ABHQN ABIPD ABJNI ABJOX ABKCH ABKTR ABMNI ABMQK ABNWP ABOCM ABPLI ABQBU ABQSL ABSXP ABTEG ABTKH ABTMW ABULA ABUWG ABWNU ABXPI ACAOD ACBXY ACDTI ACGFS ACHSB ACHXU ACKNC ACMDZ ACMLO ACOKC ACOMO ACPIV ACPRK ACSNA ACUDM ACZOJ ADBBV ADHHG ADHIR ADIMF ADINQ ADJJI ADKNI ADKPE ADRFC ADTPH ADURQ ADYFF ADZKW AEBTG AEFIE AEFQL AEGAL AEGNC AEJHL AEJRE AEKMD AEMSY AENEX AEOHA AEPYU AESKC AETLH AEVLU AEXYK AFBBN AFEXP AFKRA AFLOW AFQWF AFWTZ AFZKB AGAYW AGDGC AGGDS AGJBK AGMZJ AGQEE AGQMX AGRTI AGWIL AGWZB AGYKE AHAVH AHBYD AHIZS AHKAY AHMBA AHSBF AHYZX AIAKS AIGIU AIIXL AILAN AITGF AJBLW AJRNO AJZVZ AKMHD ALIPV ALMA_UNASSIGNED_HOLDINGS ALWAN AMKLP AMXSW AMYLF AMYQR AOCGG ARMRJ ASPBG AVWKF AXYYD AZFZN B-. BA0 BBWZM BDATZ BENPR BGNMA BPHCQ BSONS BVXVI CAG CCPQU COF CS3 CSCUP DDRTE DL5 DNIVK DPUIP DU5 EBD EBLON EBS EIOEI EJD EMOBN EN4 ESBYG F5P FEDTE FERAY FFXSO FIGPU FINBP FNLPD FRRFC FSGXE FWDCC FYUFA G-Y G-Z GGCAI GGRSB GJIRD GNWQR GQ6 GQ7 GQ8 GRRUI GXS H13 HF~ HG5 HG6 HMCUK HMJXF HQYDN HRMNR HVGLF HZ~ I09 IHE IJ- IKXTQ IMOTQ IWAJR IXC IXD IXE IZIGR IZQ I~X I~Z J-C J0Z JBSCW JCJTX JZLTJ KDC KOV KOW KPH LAK LLZTM M1P M4Y MA- N2Q N9A NB0 NDZJH NPVJJ NQJWS NU0 O9- O93 O9G O9I O9J OAM OVD P19 P2P P9S PF0 PQQKQ PROAC PSQYO PT4 PT5 Q2X QOK QOR QOS R4E R89 R9I RHV RNI ROL RPX RRX RSV RZC RZE RZK S16 S1Z S26 S27 S28 S37 S3B SAP SCLPG SDE SDH SDM SHX SISQX SJYHP SMD SNE SNPRN SNX SOHCF SOJ SPISZ SRMVM SSLCW SSXJD STPWE SV3 SZ9 SZN T13 T16 TEORI TSG TSK TSV TT1 TUC U2A U9L UG4 UKHRP UOJIU UTJUX UZXMN VC2 VFIZW W23 W48 WJK WK8 YLTOR Z45 Z7U Z82 Z87 Z8O Z8V Z91 ZMTXR ZOVNA ~A9 ~EX AAPKM AAYXX ABBRH ABDBE ABFSG ACSTC ADHKG AEZWR AFDZB AFHIU AFOHR AGQPQ AHPBZ AHWEU AIXLP ATHPR AYFIA CITATION PHGZM PHGZT NPM 7TK 7XB 8FK ABRTQ K9. PJZUB PKEHL PPXIY PQEST PQUKI PRINS 7X8 |
| ID | FETCH-LOGICAL-c375t-90cb22539b32c361f559de2e089a54fc0a3023fd8f00dc6638893d251b1b8b3b3 |
| IEDL.DBID | U2A |
| ISSN | 0929-5305 1573-742X |
| IngestDate | Thu Jul 10 18:04:40 EDT 2025 Sat Aug 23 12:53:38 EDT 2025 Wed Feb 19 02:29:19 EST 2025 Tue Jul 01 02:26:44 EDT 2025 Thu Apr 24 22:49:12 EDT 2025 Fri Feb 21 02:48:46 EST 2025 |
| IsPeerReviewed | true |
| IsScholarly | true |
| Issue | 1 |
| Keywords | Platelet aggregation Cardiovascular diseases PEAR1 Hemostasis Polymorphism |
| Language | English |
| LinkModel | DirectLink |
| MergedId | FETCHMERGED-LOGICAL-c375t-90cb22539b32c361f559de2e089a54fc0a3023fd8f00dc6638893d251b1b8b3b3 |
| Notes | ObjectType-Article-1 SourceType-Scholarly Journals-1 ObjectType-Feature-2 content type line 14 ObjectType-Review-3 content type line 23 |
| PMID | 32445063 |
| PQID | 2480135803 |
| PQPubID | 44413 |
| PageCount | 7 |
| ParticipantIDs | proquest_miscellaneous_2406304648 proquest_journals_2480135803 pubmed_primary_32445063 crossref_citationtrail_10_1007_s11239_020_02149_w crossref_primary_10_1007_s11239_020_02149_w springer_journals_10_1007_s11239_020_02149_w |
| ProviderPackageCode | CITATION AAYXX |
| PublicationCentury | 2000 |
| PublicationDate | 20210100 2021-01-00 2021-Jan 20210101 |
| PublicationDateYYYYMMDD | 2021-01-01 |
| PublicationDate_xml | – month: 1 year: 2021 text: 20210100 |
| PublicationDecade | 2020 |
| PublicationPlace | New York |
| PublicationPlace_xml | – name: New York – name: Netherlands – name: Dordrecht |
| PublicationSubtitle | A Journal for Translation, Application and Therapeutics in Thrombosis and Vascular Science |
| PublicationTitle | Journal of thrombosis and thrombolysis |
| PublicationTitleAbbrev | J Thromb Thrombolysis |
| PublicationTitleAlternate | J Thromb Thrombolysis |
| PublicationYear | 2021 |
| Publisher | Springer US Springer Nature B.V |
| Publisher_xml | – name: Springer US – name: Springer Nature B.V |
| References | Kardeby, Falker, Haining (CR26) 2019; 3 Izzi, Pistoni, Cludts (CR45) 2016; 128 Xiang, Cui, Zhao (CR40) 2013; 14 Faraday, Yanek, Yang (CR7) 2011; 118 Faraday, Becker, Yanek (CR30) 2006; 98 Peng, Zhao, Zhou (CR46) 2016; 37 Nie, Li, Qin (CR39) 2018; 163 Kim, Suktitipat, Yanek (CR4) 2013; 8 Elwood, Renaud, Sharp (CR20) 1991; 83 Getz, Manne, Buitrago (CR24) 2013; 109 Roberts, Stewart (CR43) 2012; 60 Farré, Modrego, Zamorano-León (CR3) 2014; 18 Kauskot, Vandenbriele, Louwette (CR14) 2013; 121 Yao, Tang, Zhang (CR21) 2016; 141 Mozaffarian, Benjamin (CR2) 2016; 133 Fisch, Yerges-Armstrong, Backman (CR44) 2015; 10 Li, Hu, Wen (CR8) 2017; 47 Vandenbriele, Sun, Criel (CR15) 2016; 27 Stimpfle, Bauer, Rath (CR41) 2018; 9 Jones, Bray, Garner (CR19) 2009; 114 CR6 Sun, Vandenbriele, Kauskot (CR12) 2015; 14 Criel, Izzi, Vandenbriele (CR13) 2016; 146 Wurtz, Nissen, Grove (CR32) 2014; 9 Kardeby, Fälker, Haining (CR17) 2019; 3 CR28 Kauskot, Di Michele, Loyen (CR5) 2012; 119 Yao, Tang, He (CR22) 2018; 25 Nanda, Bao, Lin (CR10) 2005; 280 Lewis, Ryan, O’connell (CR36) 2013; 6 Xu, Liu, Ott (CR29) 2018; 388 Nawarskas, Montoya (CR34) 2018; 26 Olivi, Vandenbriele, Gu (CR42) 2015; 24 Fu, Sun, Liang (CR47) 2016; 95 Lavie, Arena, Alpert (CR1) 2018; 15 Izzi, Noro, Cludts (CR37) 2018; 19 Xu, Ye, Zhang (CR9) 2019; 12 Herrera-Galeano, Becker, Wilson (CR31) 2008; 28 Johnson (CR38) 2016; 128 Pi, Xu, Fu (CR11) 2019; 83 Zhang, Zhu, Li (CR33) 2018; 140 Shahrabi, Behzad, Jaseb (CR27) 1976; 2018 Keramati, Yanek, Iyer (CR23) 2018; 19 Faraday, Yanek, Mathias (CR35) 2007; 115 Johnson, Yanek, Chen (CR48) 2010; 42 Nanda, Phillips (CR16) 2006; 36 Yang, Petit, Cauwenberghs (CR18) 2017; 18 Alshehri, Montague, Watson (CR25) 2015; 468 D Mozaffarian (2149_CR2) 2016; 133 N Nanda (2149_CR16) 2006; 36 TM Getz (2149_CR24) 2013; 109 AD Johnson (2149_CR48) 2010; 42 M Wurtz (2149_CR32) 2014; 9 2149_CR28 AR Keramati (2149_CR23) 2018; 19 Y Yao (2149_CR21) 2016; 141 L Pi (2149_CR11) 2019; 83 JE Herrera-Galeano (2149_CR31) 2008; 28 N Nanda (2149_CR10) 2005; 280 B Izzi (2149_CR37) 2018; 19 R Roberts (2149_CR43) 2012; 60 Y Yao (2149_CR22) 2018; 25 CJ Lavie (2149_CR1) 2018; 15 N Faraday (2149_CR35) 2007; 115 AS Fisch (2149_CR44) 2015; 10 CI Jones (2149_CR19) 2009; 114 F Stimpfle (2149_CR41) 2018; 9 B Izzi (2149_CR45) 2016; 128 Y Fu (2149_CR47) 2016; 95 LL Peng (2149_CR46) 2016; 37 A Kauskot (2149_CR5) 2012; 119 S Shahrabi (2149_CR27) 1976; 2018 S Zhang (2149_CR33) 2018; 140 OM Alshehri (2149_CR25) 2015; 468 A Kauskot (2149_CR14) 2013; 121 AL Farré (2149_CR3) 2014; 18 Y Kim (2149_CR4) 2013; 8 M Li (2149_CR8) 2017; 47 C Vandenbriele (2149_CR15) 2016; 27 JJ Nawarskas (2149_CR34) 2018; 26 L Olivi (2149_CR42) 2015; 24 JP Lewis (2149_CR36) 2013; 6 XY Nie (2149_CR39) 2018; 163 K Xu (2149_CR9) 2019; 12 AD Johnson (2149_CR38) 2016; 128 PC Elwood (2149_CR20) 1991; 83 N Faraday (2149_CR7) 2011; 118 C Kardeby (2149_CR26) 2019; 3 N Faraday (2149_CR30) 2006; 98 Y Sun (2149_CR12) 2015; 14 M Criel (2149_CR13) 2016; 146 Q Xiang (2149_CR40) 2013; 14 WY Yang (2149_CR18) 2017; 18 2149_CR6 C Kardeby (2149_CR17) 2019; 3 K Xu (2149_CR29) 2018; 388 |
| References_xml | – volume: 14 start-page: 1265 issue: 5 year: 2015 end-page: 1274 ident: CR12 article-title: A human platelet receptor protein microarray identifies the high affinity immunoglobulin E receptor subunit alpha (FcepsilonR1alpha) as an Activating Platelet Endothelium Aggregation Receptor 1 (PEAR1) ligand publication-title: Mol Cell Proteomics doi: 10.1074/mcp.M114.046946 – volume: 36 start-page: 228 issue: 2 year: 2006 end-page: 231 ident: CR16 article-title: Novel targets for antithrombotic drug discovery publication-title: Blood Cells Mol Dis doi: 10.1016/j.bcmd.2005.12.026 – volume: 2018 start-page: 11976 year: 1976 end-page: 11981 ident: CR27 article-title: Thrombocytopenia in leukemia: pathogenesis and prognosis publication-title: Histol Histopathol – volume: 6 start-page: 184 issue: 2 year: 2013 end-page: 192 ident: CR36 article-title: Genetic variation in PEAR1 is associated with platelet aggregation and cardiovascular outcomes clinical perspective publication-title: Circulation – volume: 12 start-page: e007019 issue: 5 year: 2019 ident: CR9 article-title: Impact of platelet endothelial aggregation receptor-1 genotypes on platelet reactivity and early cardiovascular outcomes in patients undergoing percutaneous coronary intervention and treated with aspirin and clopidogrel publication-title: Circulation – volume: 19 start-page: 1069 issue: 4 year: 2018 ident: CR37 article-title: Cell-specific PEAR1 methylation studies reveal a locus that coordinates expression of multiple genes publication-title: Int J Mol Sci doi: 10.3390/ijms19041069 – volume: 9 start-page: e111816 issue: 10 year: 2014 ident: CR32 article-title: Genetic determinants of on-aspirin platelet reactivity: focus on the influence of PEAR1 publication-title: PLoS ONE doi: 10.1371/journal.pone.0111816 – volume: 468 start-page: 459 issue: 3 year: 2015 end-page: 473 ident: CR25 article-title: Activation of glycoprotein VI (GPVI) and C-type lectin-like receptor-2 (CLEC-2) underlies platelet activation by diesel exhaust particles and other charged/hydrophobic ligands publication-title: Biochem J doi: 10.1042/bj20150192 – volume: 133 start-page: e38 issue: 4 year: 2016 ident: CR2 article-title: Heart disease and stroke statistics-2016 update: a report from the American Heart Association publication-title: Circulation – volume: 9 start-page: 490 year: 2018 ident: CR41 article-title: Variants of PEAR1 are associated with outcome in patients with ACS and stable CAD undergoing PCI publication-title: Front Pharmacol doi: 10.3389/fphar.2018.00490 – volume: 60 start-page: 1715 issue: 18 year: 2012 end-page: 1721 ident: CR43 article-title: Genes and coronary artery disease: where are we? publication-title: Am Coll Cardiol doi: 10.1016/j.jacc.2011.12.062 – volume: 118 start-page: 3367 issue: 12 year: 2011 end-page: 3375 ident: CR7 article-title: Identification of a specific intronic PEAR1 gene variant associated with greater platelet aggregability and protein expression publication-title: Blood doi: 10.1182/blood-2010-11-320788 – volume: 114 start-page: 1405 issue: 7 year: 2009 end-page: 1416 ident: CR19 article-title: A functional genomics approach reveals novel quantitative trait loci associated with platelet signaling pathways publication-title: Blood doi: 10.1182/blood-2009-02-202614 – ident: CR6 – volume: 163 start-page: 77 year: 2018 end-page: 82 ident: CR39 article-title: Genetic mutations in PEAR1 associated with cardiovascular outcomes in Chinese patients with acute coronary syndrome publication-title: Thromb Res doi: 10.1016/j.thromres.2018.01.026 – volume: 128 start-page: 1003 issue: 7 year: 2016 end-page: 1012 ident: CR45 article-title: Allele-specific DNA methylation reinforces PEAR1 enhancer activity publication-title: Blood doi: 10.1182/blood-2015-11-682153 – volume: 3 start-page: 275 issue: 3 year: 2019 end-page: 287 ident: CR26 article-title: Synthetic glycopolymers and natural fucoidans cause human platelet aggregation via PEAR1 and GPIbalpha publication-title: Blood Adv doi: 10.1182/bloodadvances.2018024950 – volume: 83 start-page: 38 issue: 1 year: 1991 end-page: 44 ident: CR20 article-title: Ischemic heart disease and platelet aggregation publication-title: Caerphilly Collab Heart Dis Stud – volume: 19 start-page: 1 year: 2018 end-page: 7 ident: CR23 article-title: Targeted deep sequencing of the PEAR1 locus for platelet aggregation in European and African American families publication-title: Platelets doi: 10.1080/09537104.2018.1447659 – volume: 28 start-page: 1484 issue: 8 year: 2008 end-page: 1490 ident: CR31 article-title: A novel variant in the platelet endothelial aggregation receptor-1 gene is associated with increased platelet aggregability publication-title: Arterioscl Thrombo Vasc Biol doi: 10.1161/atvbaha.108.168971 – volume: 115 start-page: 2490 issue: 19 year: 2007 end-page: 2496 ident: CR35 article-title: Heritability of platelet responsiveness to aspirin in activation pathways directly and indirectly related to cyclooxygenase-1 publication-title: Circulation doi: 10.1161/circulationaha.106.667584 – volume: 280 start-page: 24680 issue: 26 year: 2005 end-page: 24689 ident: CR10 article-title: Platelet endothelial aggregation receptor 1 (PEAR1), a novel epidermal growth factor repeat-containing transmembrane receptor, participates in platelet contact-induced activation publication-title: J Biol Chem doi: 10.1074/jbc.M413411200 – volume: 128 start-page: 890 issue: 7 year: 2016 end-page: 892 ident: CR38 article-title: Pairing megakaryopoiesis methylation with PEAR1 publication-title: Blood doi: 10.1182/blood-2016-06-723940 – volume: 109 start-page: 1131 issue: 6 year: 2013 end-page: 1140 ident: CR24 article-title: Dextran sulphate induces fibrinogen receptor activation through a novel Syk-independent PI-3 kinase-mediated tyrosine kinase pathway in platelets publication-title: Thromb Haemost doi: 10.1160/th12-09-0645 – volume: 18 start-page: 27 issue: 1 year: 2014 end-page: 36 ident: CR3 article-title: Effects of hormones on platelet aggregation publication-title: Hormone Mol Biol Clin Investig doi: 10.1515/hmbci-2013-0055 – volume: 37 start-page: 1442 issue: 11 year: 2016 end-page: 1448 ident: CR46 article-title: Associations of MDR1, TBXA2R, PLA2G7, and PEAR1 genetic polymorphisms with the platelet activity in Chinese ischemic stroke patients receiving aspirin therapy publication-title: Acta Pharmacol Sin doi: 10.1038/aps.2016.90 – volume: 121 start-page: 5208 issue: 26 year: 2013 end-page: 5217 ident: CR14 article-title: PEAR1 attenuates megakaryopoiesis via control of the PI3K/PTEN pathway publication-title: Blood doi: 10.1182/blood-2012-10-462887 – volume: 27 start-page: 365 issue: 4 year: 2016 end-page: 372 ident: CR15 article-title: Dextran sulfate triggers platelet aggregation via direct activation of PEAR1 publication-title: Platelets doi: 10.3109/09537104.2015.1111321 – volume: 388 start-page: 141 year: 2018 end-page: 145 ident: CR29 article-title: The combined effects of cardiovascular disease related SNPs on ischemic stroke publication-title: J Neurol Sci doi: 10.1016/j.jns.2018.03.013 – volume: 47 start-page: 1130 issue: 12 year: 2017 end-page: 1138 ident: CR8 article-title: Association of PEAR1 rs12041331 polymorphism and pharmacodynamics of ticagrelor in healthy Chinese volunteers publication-title: Xenobiotica doi: 10.1080/00498254.2016.1271962 – volume: 95 start-page: e5687 issue: 51 year: 2016 ident: CR47 article-title: PEAR1 gene polymorphism in a Chinese pedigree with pulmonary thromboembolism publication-title: Medicine doi: 10.1097/md.0000000000005687 – volume: 146 start-page: 76 year: 2016 end-page: 83 ident: CR13 article-title: Absence of Pear1 does not affect murine platelet function in vivo publication-title: Thrombosis Res doi: 10.1016/j.thromres.2016.08.026 – volume: 140 start-page: 21 issue: 1 year: 2018 end-page: 29 ident: CR33 article-title: Study of the association of PEAR1, P2Y12, and UGT2A1 polymorphisms with platelet reactivity in response to dual antiplatelet therapy in Chinese patients publication-title: Cardiology doi: 10.1159/000488101 – volume: 83 start-page: 54 issue: 1 year: 2019 end-page: 62 ident: CR11 article-title: A PEAR1 polymorphism (rs12041331) is associated with risk of coronary artery aneurysm in Kawasaki disease publication-title: Ann Hum Genet doi: 10.1111/ahg.12285 – volume: 14 start-page: 1179 issue: 10 year: 2013 end-page: 1189 ident: CR40 article-title: Identification of PEAR1 SNPs and their influences on the variation in prasugrel pharmacodynamics publication-title: Pharmacogenomics doi: 10.2217/pgs.13.108 – volume: 98 start-page: 774 issue: 6 year: 2006 end-page: 779 ident: CR30 article-title: Relation between atherosclerosis risk factors and aspirin resistance in a primary prevention population publication-title: Am J Cardiol doi: 10.1016/j.amjcard.2006.04.015 – volume: 15 start-page: 45 issue: 1 year: 2018 ident: CR1 article-title: Management of cardiovascular diseases in patients with obesity publication-title: Nat Rev Cardiol doi: 10.1038/nrcardio.2017.108 – volume: 8 start-page: e64179 issue: 5 year: 2013 ident: CR4 article-title: Targeted deep resequencing identifies coding variants in the PEAR1 gene that play a role in platelet aggregation publication-title: PLoS ONE doi: 10.1371/journal.pone.0064179 – volume: 141 start-page: 28 year: 2016 end-page: 34 ident: CR21 article-title: Association of PEAR1 genetic variants with platelet reactivity in response to dual antiplatelet therapy with aspirin and clopidogrel in the Chinese patient population after percutaneous coronary intervention publication-title: Thromb Res doi: 10.1016/j.thromres.2016.02.031 – volume: 119 start-page: 4056 issue: 17 year: 2012 end-page: 4065 ident: CR5 article-title: A novel mechanism of sustained platelet αIIbβ3 activation via PEAR1 publication-title: Blood J Am Soc Hematol – volume: 25 start-page: 454 issue: 5 year: 2018 end-page: 459 ident: CR22 article-title: Effect of PEAR1 genetic variants on 1-year outcomes in chinese patients with acute myocardial infarction after percutaneous coronary intervention publication-title: J Atheroscler Thromb doi: 10.5551/jat.39982 – volume: 26 start-page: 107 issue: 2 year: 2018 end-page: 111 ident: CR34 article-title: Switching from ticagrelor or prasugrel to clopidogrel publication-title: Cardiol Rev doi: 10.1097/crd.0000000000000181 – volume: 18 start-page: 45 issue: 1 year: 2017 ident: CR18 article-title: PEAR1 is not a major susceptibility gene for cardiovascular disease in a Flemish population publication-title: BMC Med Genet doi: 10.1186/s12881-017-0411-x – ident: CR28 – volume: 24 start-page: 61 issue: 1 year: 2015 end-page: 64 ident: CR42 article-title: PEAR1 is not a human hypertension-susceptibility gene publication-title: Blodd Press doi: 10.3109/08037051.2014.986928 – volume: 3 start-page: 275 issue: 3 year: 2019 end-page: 287 ident: CR17 article-title: Synthetic glycopolymers and natural fucoidans cause human platelet aggregation via PEAR1 and GPIbα publication-title: Blood Adv doi: 10.1182/bloodadvances.2018024950 – volume: 10 start-page: e0138795 issue: 9 year: 2015 ident: CR44 article-title: Genetic variation in the platelet endothelial aggregation receptor 1 gene results in endothelial dysfunction publication-title: PLoS ONE doi: 10.1371/journal.pone.0138795 – volume: 42 start-page: 608 issue: 7 year: 2010 ident: CR48 article-title: Genome-wide meta-analyses identifies seven loci associated with platelet aggregation in response to agonists publication-title: Nat Genet doi: 10.1038/ng.604 – volume: 25 start-page: 454 issue: 5 year: 2018 ident: 2149_CR22 publication-title: J Atheroscler Thromb doi: 10.5551/jat.39982 – volume: 128 start-page: 890 issue: 7 year: 2016 ident: 2149_CR38 publication-title: Blood doi: 10.1182/blood-2016-06-723940 – volume: 95 start-page: e5687 issue: 51 year: 2016 ident: 2149_CR47 publication-title: Medicine doi: 10.1097/md.0000000000005687 – volume: 26 start-page: 107 issue: 2 year: 2018 ident: 2149_CR34 publication-title: Cardiol Rev doi: 10.1097/crd.0000000000000181 – volume: 118 start-page: 3367 issue: 12 year: 2011 ident: 2149_CR7 publication-title: Blood doi: 10.1182/blood-2010-11-320788 – volume: 115 start-page: 2490 issue: 19 year: 2007 ident: 2149_CR35 publication-title: Circulation doi: 10.1161/circulationaha.106.667584 – volume: 27 start-page: 365 issue: 4 year: 2016 ident: 2149_CR15 publication-title: Platelets doi: 10.3109/09537104.2015.1111321 – volume: 14 start-page: 1179 issue: 10 year: 2013 ident: 2149_CR40 publication-title: Pharmacogenomics doi: 10.2217/pgs.13.108 – volume: 468 start-page: 459 issue: 3 year: 2015 ident: 2149_CR25 publication-title: Biochem J doi: 10.1042/bj20150192 – volume: 60 start-page: 1715 issue: 18 year: 2012 ident: 2149_CR43 publication-title: Am Coll Cardiol doi: 10.1016/j.jacc.2011.12.062 – volume: 98 start-page: 774 issue: 6 year: 2006 ident: 2149_CR30 publication-title: Am J Cardiol doi: 10.1016/j.amjcard.2006.04.015 – volume: 15 start-page: 45 issue: 1 year: 2018 ident: 2149_CR1 publication-title: Nat Rev Cardiol doi: 10.1038/nrcardio.2017.108 – volume: 10 start-page: e0138795 issue: 9 year: 2015 ident: 2149_CR44 publication-title: PLoS ONE doi: 10.1371/journal.pone.0138795 – volume: 133 start-page: e38 issue: 4 year: 2016 ident: 2149_CR2 publication-title: Circulation – volume: 19 start-page: 1069 issue: 4 year: 2018 ident: 2149_CR37 publication-title: Int J Mol Sci doi: 10.3390/ijms19041069 – volume: 47 start-page: 1130 issue: 12 year: 2017 ident: 2149_CR8 publication-title: Xenobiotica doi: 10.1080/00498254.2016.1271962 – volume: 19 start-page: 1 year: 2018 ident: 2149_CR23 publication-title: Platelets doi: 10.1080/09537104.2018.1447659 – volume: 119 start-page: 4056 issue: 17 year: 2012 ident: 2149_CR5 publication-title: Blood J Am Soc Hematol – volume: 18 start-page: 27 issue: 1 year: 2014 ident: 2149_CR3 publication-title: Hormone Mol Biol Clin Investig doi: 10.1515/hmbci-2013-0055 – volume: 140 start-page: 21 issue: 1 year: 2018 ident: 2149_CR33 publication-title: Cardiology doi: 10.1159/000488101 – volume: 42 start-page: 608 issue: 7 year: 2010 ident: 2149_CR48 publication-title: Nat Genet doi: 10.1038/ng.604 – volume: 36 start-page: 228 issue: 2 year: 2006 ident: 2149_CR16 publication-title: Blood Cells Mol Dis doi: 10.1016/j.bcmd.2005.12.026 – volume: 388 start-page: 141 year: 2018 ident: 2149_CR29 publication-title: J Neurol Sci doi: 10.1016/j.jns.2018.03.013 – volume: 18 start-page: 45 issue: 1 year: 2017 ident: 2149_CR18 publication-title: BMC Med Genet doi: 10.1186/s12881-017-0411-x – volume: 109 start-page: 1131 issue: 6 year: 2013 ident: 2149_CR24 publication-title: Thromb Haemost doi: 10.1160/th12-09-0645 – volume: 14 start-page: 1265 issue: 5 year: 2015 ident: 2149_CR12 publication-title: Mol Cell Proteomics doi: 10.1074/mcp.M114.046946 – volume: 37 start-page: 1442 issue: 11 year: 2016 ident: 2149_CR46 publication-title: Acta Pharmacol Sin doi: 10.1038/aps.2016.90 – volume: 12 start-page: e007019 issue: 5 year: 2019 ident: 2149_CR9 publication-title: Circulation – volume: 114 start-page: 1405 issue: 7 year: 2009 ident: 2149_CR19 publication-title: Blood doi: 10.1182/blood-2009-02-202614 – volume: 2018 start-page: 11976 year: 1976 ident: 2149_CR27 publication-title: Histol Histopathol – volume: 8 start-page: e64179 issue: 5 year: 2013 ident: 2149_CR4 publication-title: PLoS ONE doi: 10.1371/journal.pone.0064179 – volume: 128 start-page: 1003 issue: 7 year: 2016 ident: 2149_CR45 publication-title: Blood doi: 10.1182/blood-2015-11-682153 – volume: 141 start-page: 28 year: 2016 ident: 2149_CR21 publication-title: Thromb Res doi: 10.1016/j.thromres.2016.02.031 – volume: 6 start-page: 184 issue: 2 year: 2013 ident: 2149_CR36 publication-title: Circulation – volume: 3 start-page: 275 issue: 3 year: 2019 ident: 2149_CR17 publication-title: Blood Adv doi: 10.1182/bloodadvances.2018024950 – volume: 9 start-page: 490 year: 2018 ident: 2149_CR41 publication-title: Front Pharmacol doi: 10.3389/fphar.2018.00490 – volume: 83 start-page: 54 issue: 1 year: 2019 ident: 2149_CR11 publication-title: Ann Hum Genet doi: 10.1111/ahg.12285 – ident: 2149_CR28 doi: 10.1080/10428194.2019.1630622 – volume: 146 start-page: 76 year: 2016 ident: 2149_CR13 publication-title: Thrombosis Res doi: 10.1016/j.thromres.2016.08.026 – volume: 9 start-page: e111816 issue: 10 year: 2014 ident: 2149_CR32 publication-title: PLoS ONE doi: 10.1371/journal.pone.0111816 – volume: 3 start-page: 275 issue: 3 year: 2019 ident: 2149_CR26 publication-title: Blood Adv doi: 10.1182/bloodadvances.2018024950 – volume: 163 start-page: 77 year: 2018 ident: 2149_CR39 publication-title: Thromb Res doi: 10.1016/j.thromres.2018.01.026 – volume: 280 start-page: 24680 issue: 26 year: 2005 ident: 2149_CR10 publication-title: J Biol Chem doi: 10.1074/jbc.M413411200 – volume: 28 start-page: 1484 issue: 8 year: 2008 ident: 2149_CR31 publication-title: Arterioscl Thrombo Vasc Biol doi: 10.1161/atvbaha.108.168971 – volume: 24 start-page: 61 issue: 1 year: 2015 ident: 2149_CR42 publication-title: Blodd Press doi: 10.3109/08037051.2014.986928 – ident: 2149_CR6 doi: 10.1007/s12094-019-02132-9 – volume: 121 start-page: 5208 issue: 26 year: 2013 ident: 2149_CR14 publication-title: Blood doi: 10.1182/blood-2012-10-462887 – volume: 83 start-page: 38 issue: 1 year: 1991 ident: 2149_CR20 publication-title: Caerphilly Collab Heart Dis Stud |
| SSID | ssj0009902 |
| Score | 2.3193111 |
| SecondaryResourceType | review_article |
| Snippet | Platelet Endothelial Aggregation Receptor (PEAR1), as a platelet receptor, plays a vital role in hemostasis. This receptor, by its extracellular part, causes... |
| SourceID | proquest pubmed crossref springer |
| SourceType | Aggregation Database Index Database Enrichment Source Publisher |
| StartPage | 89 |
| SubjectTerms | Cardiology Cardiovascular diseases Genetic screening Hematology Hemostasis Homeostasis Medicine Medicine & Public Health Platelet aggregation Risk factors |
| SummonAdditionalLinks | – databaseName: Health & Medical Collection dbid: 7X7 link: http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwfV3dS-QwEB88BbkX8eM8q6tEuDcvmDZpt3mSRRQRFDkU9q3ko8UFbVe74r_vTJvdReSEPrVpG2YyyW8yk98A_DGJTz2aDa-MzLjSMubGJim36AHlIjOVlHTA-eY2u3pQ1-N0HDbc2pBWOZ8Tu4naN472yE8T4jmhmJ08m75wqhpF0dVQQuMHrBF1GTlfw_FwSbrb5xwKhAA8xYEdDs30R-dwytacnCdiDdP8_fPC9AVtfomUdgvQ5SZsBOTIRr2qt2ClrLdh_SbExnfg_u5i9C9m0-YJ3XmU3qR9bpnBi1EOVt0QITPry-uwSc0ey2e8ZdoJtqg9c5_yUlmI27S_4OHy4v78ioeaCdzJYTrjWjiLJiq1lYmTWVyhx-DLpBS5NqmqnDBUJajyeSWEdwg3cgQsHkGOjW1upZW7sFo3dbkHLM1cbnLhtBoqpTOjfeWc8FVWeuOdNxHEc4EVLhCKU12Lp2JJhUxCLlDIRSfk4j2Ck8U7055O49vWg7keimBabbEcCBEcLx6jUVCkw9Rl80ZtiEpMZSqP4Hevv8XvEEGqFB9H8Heu0OXH_9-X_e_7cgA_E8p26TZnBrA6e30rDxGuzOxRNyY_ALnT5OY priority: 102 providerName: ProQuest |
| Title | PEAR1 polymorphisms as a prognostic factor in hemostasis and cardiovascular diseases |
| URI | https://link.springer.com/article/10.1007/s11239-020-02149-w https://www.ncbi.nlm.nih.gov/pubmed/32445063 https://www.proquest.com/docview/2480135803 https://www.proquest.com/docview/2406304648 |
| Volume | 51 |
| hasFullText | 1 |
| inHoldings | 1 |
| isFullTextHit | |
| isPrint | |
| link | http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwlV3rS-NAEB_UwnFf5PQe5k7LCn47FzbZ3TT7sZVWUVpELNRPYR8JV7BpMRX__ZvNo0U8D4TAQnayCTP7mMnM_AbgTEdOOlw2NNc8pkLxkGoTSWrQAkpYrHPOfYLzeBJfTcX1TM6apLCyjXZvXZLVTr1NdsNNVlFv7nicL0VfdqEj0Xb383oa9bdQu3WkIcODn0qczk2qzL_HeH0cvdEx3_hHq2Nn9AX2G32R9GsBH8BOVhzCp3HjEf8K97fD_l1IVstHNOKRZ_NyURKNF_GRV8XSwzCTuqgOmRfkT7bAW7qcI0XhiH0VjUoab035Daaj4f3FFW0qJVDLe3JNFbMGFyZXhkeWx2GOdoLLoowlSkuRW6Z9baDcJTljzqKSkaCa4lC1MaFJDDf8O-wVyyI7AiJjm-iEWSV6QqhYK5dby1weZ04763QAYcuw1DYw4r6axWO6BUD2TE6RyWnF5PQlgN-bZ1Y1iMZ_qY9bOaTNgirTyMPceJctD-B0041Lwfs3dJEtnz2NBxATsUgC-FHLb_M61BuFxO4AzluBbgd__1t-foz8F3yOfMxL9YvmGPbWT8_ZCSota9OF3d6s14VOfzQYTHx7-XAzxHYwnNzedasZ_BfF4ufm |
| linkProvider | Springer Nature |
| linkToHtml | http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwtV1Lb9QwEB6VIgEXVN6BFowEJ7DqxE42PqCqKq22tFshtJX2FvxIxErdZCFbrfqn-I3M5LGrqqK3SjnFjmPNwzP2jL8B-GAiH3tUG14YmXClZciNjWJucQeUisQUUtIF59FZMjxX3ybxZAP-9ndhKK2yXxObhdpXjs7IdyPCOaGYndyb_-ZUNYqiq30JjVYsTvKrJW7Z6i_HX5G_H6Po6HB8MORdVQHu5CBecC2cRSGW2srIySQs0Kf2eZSLVJtYFU4YqqNT-LQQwjs0yCmadI9ugA1taqWVOO49uI-GV1AK4WAyWIP8tjmOAl0OHqMidZd02qt6aCI0p80aoZRpvrxuCG94tzcis43BO9qCx52nyvZb0XoCG3n5FB6Mulj8Mxh_P9z_EbJ5dXE1q5Bb03pWM4MPo5yvsiIAaNaW82HTkv3KZ_jK1FPsUXrmruXBsi5OVD-H8zuh5gvYLKsyfwUsTlxqUuG0GiilE6N94ZzwRZJ74503AYQ9wTLXAZhTHY2LbA29TETOkMhZQ-RsGcCn1TfzFr7j1t7bPR-yTpXrbC14AbxfNaMSUmTFlHl1SX0IukwlKg3gZcu_1e_QY1UxNgfwuWfoevD_z-X17XN5Bw-H49Fpdnp8dvIGHkWUadMcDG3D5uLPZb6DrtLCvm3kk8HPu1aIf5xnIL4 |
| linkToPdf | http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwtV1La9wwEB7SFEIvpe-4SVsV2lMrIlvyQ4dSQpMlaZoQSgJ7c_WkC1l7G29Y8tf66zryY5cQmlvAJ0uWxTw0I83oG4APKrGpRbWhXvGMCsljqnSSUo07oIJlynMeLjgfn2QH5-L7OB2vwd_hLkxIqxzWxHahtrUJZ-Q7ScA5CTE7vuP7tIjTvdHX2R8aKkiFSOtQTqMTkSN3vcDtW_PlcA95_TFJRvtn3w5oX2GAGp6ncyqZ0SjQXGqeGJ7FHv1r6xLHCqlS4Q1ToaaOt4VnzBo0zgWad4sugY51obnmOO4DeJhzNJuoS_k4XwH-dvmODN0PmqJS9Rd2umt7aC4kDRu3gFgm6eKmUbzl6d6K0rbGb_QEHvdeK9ntxOwprLnqGWwc93H553B2ur_7Myaz-uJ6WiPnJs20IQofEvK_qjqAQZOutA-ZVOS3m-Ir1UywR2WJuZETS_qYUfMCzu-Fmi9hvaortwkkzUyhCmakyIWQmZLWG8Osz5xV1lgVQTwQrDQ9mHmoqXFRrmCYA5FLJHLZErlcRPBp-c2sg_K4s_f2wIeyV-umXAlhBO-XzaiQIcqiKldfhT4BxkxkoojgVce_5e_QexUpNkfweWDoavD_z-X13XN5BxuoCuWPw5OjLXiUhKSb9oxoG9bnl1fuDXpNc_22FU8Cv-5bH_4BMdok9A |
| openUrl | ctx_ver=Z39.88-2004&ctx_enc=info%3Aofi%2Fenc%3AUTF-8&rfr_id=info%3Asid%2Fsummon.serialssolutions.com&rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&rft.genre=article&rft.atitle=PEAR1+polymorphisms+as+a+prognostic+factor+in+hemostasis+and+cardiovascular+diseases&rft.jtitle=Journal+of+thrombosis+and+thrombolysis&rft.au=Ansari%2C+Narges&rft.au=Najafi%2C+Sahar&rft.au=Shahrabi%2C+Saied&rft.au=Saki%2C+Najmaldin&rft.date=2021-01-01&rft.issn=0929-5305&rft.eissn=1573-742X&rft.volume=51&rft.issue=1&rft.spage=89&rft.epage=95&rft_id=info:doi/10.1007%2Fs11239-020-02149-w&rft.externalDBID=n%2Fa&rft.externalDocID=10_1007_s11239_020_02149_w |
| thumbnail_l | http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/lc.gif&issn=0929-5305&client=summon |
| thumbnail_m | http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/mc.gif&issn=0929-5305&client=summon |
| thumbnail_s | http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/sc.gif&issn=0929-5305&client=summon |